All In MedTech

Device Trial Radar · NCT06514196

Post- Approval Hintermann Series H® Study 1

Post- Approval Study 1: Long Term Follow Up of the Hintermann Series H® Total Ankle Replacement System

Last checked: Nov 20, 2026Latest source record: Jul 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

298

Planned (sponsor's estimate)

Start

Jun 18, 2020

Primary completion

Nov 30, 2024

Study completion Jan 20, 2025

Sponsor

Lead sponsor
DT MedTech, LLCNot on our public-company list
Sponsor type
Industry
First posted
Jul 23, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The H3 TAR device received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) on June 4, 2019, and as a condition of that approval, this study is being conducted to provide long-term safety and effectiveness of the H3 TAR System among patients included in the Primary Safety and Effectiveness (PSE) Cohort (P1600361). This will be a Prospective, single-center, single arm study.

Conditions

  • Ankle Osteoarthritis
  • Post-Traumatic Osteoarthritis of Ankle
  • Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)

Interventions

  • Hintermann Series H3 Total Ankle Replacement SystemDevice

    The H3 includes a metal tibial component, a polyethylene sliding insert (PE inlay), and a metal talar component.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AOFAS Score MeasurementTime frame: 10 Years
  2. Survivorship MeasurementTime frame: 10 Years
  3. Serious device-related adverse event MeasurementTime frame: 10 Years

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kantonsspital Baselland

    Bruderholz, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.